Postdoctoral Research Fellow, Ironwood Pharmaceuticals--Clinical Development and Medical Scientific Affairs

About the Opportunity

About the Opportunity: 

Northeastern University Pharmaceutical Industry Fellowships Program is a two-year experiential program designed to advance lifelong learning and the education and training of Pharm.D. graduates. Critical to the success of the program is our ability to prepare Fellows to meet the ongoing workforce needs in various areas of industry.  

Our program gives fellows an opportunity to work with our innovative biopharmaceutical industry partners while collaborating with Northeastern University faculty in professional and career development, service, scholarship, and teaching. 

In partnership with Northeastern University, Ironwood Pharmaceuticals is offering a two-year Clinical Development /Medical Scientific Affairs (CD/MSA) PharmD fellowship based in Boston. 

Company Summary: 

Ironwood Pharmaceuticals is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), which is the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) and is also indicated for the treatment of functional constipation in pediatric patients ages 6-17 years old. Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure (SBS-IF), as well as several earlier stage assets.  

Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs. With a seasoned GI leadership team at the helm, deep relationships within the GI community, and a proven track record of success, we are poised to unearth new opportunities to create next-generation GI advancements.  

Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts, with a site in Basel, Switzerland. 

Responsibilities: 

The purpose of the Clinical Development /Medical Scientific Affairs(CD/MSA) Fellowship is to allow the fellow to learn how to perform as an individual contributor within the Clinical Development (CD) and Medical Scientific Affairs (MSA) group. The cross-functional collaboration between these two groups is essential to both the development of a commercialized therapeutic product and management of that product throughout its life cycle. The fellow will contribute to the design and implementation of complex strategic medical affairs plans for Ironwood GI products and will acquire in-depth GI disease states knowledge. 

During the first year of the fellowship, the fellow will work within the clinical development team to gain experience in clinical research and study design, development, and execution, as well as study results interpretation.   

During the second year of the fellowship, the fellow be integrated within the medical affairs team to gain experience in medical strategy, Medical Legal Regulatory (MLR) review, publication strategy, content development, advisory board and congress strategy, and insight generation.  

In both functions, the fellow will have the opportunity to work collaboratively with the other functional areas within Ironwood including regulatory, global patient safety, commercial, data sciences, and medical writing, as well as experience partner interactions and engage in vendor oversight. Additionally, the fellow will have the opportunity to precept students.  

Year 1: Clinical Development and Rotation of Interest 

• Develop and execute